✦ LIBER ✦

P2.091 D1 antagonist blocks L-DOPA-induced striatal and nigral ERK1/2 phosphorylation in a rat model of Parkinson's disease

✍ Scribed by S. Sivam; C. Moreno

Book ID: 117753645
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 61 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(09)70442-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2.505 L-DOPA induces microvascular chang

2.505 L-DOPA induces microvascular changes in the basal ganglia through the D1 receptor in a rat model of Parkinson's disease

✍ E. Ohlin; H.S. Lindgren; M.A. Cenci 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

P2.157 Metabotropic glutamate receptor t

P2.157 Metabotropic glutamate receptor type 5 (mGluR5) antagonists improve L-DOPA-induced-dyskinesia in both rat and macaque models of Parkinson's disease

✍ D. Rylander; Q. Li; A. Dekundy; H. Li; R. Baishen; W. Danysz; E. Bezard; A. Cenc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Differential interaction of competitive

Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease

✍ Peter-Andreas Löschmann; Ullrich Wüllner; Michael T. Heneka; Jörg B. Schulz; Mar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 3 views

1-aminomethyl-5,6-dihydroxy-3-phenylisochroman; NMDA antagonist; CPP; 3-((6)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid

Striatal fosB Expression Is Causally Lin

Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's Disease

✍ M. Andersson; A. Hilbertson; M.A. Cenci 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 488 KB